Ann: Letter to Shareholders, page-125

I'll take my advice from the company not you and your biased interpretations.

Right now they've told us they think they are having some effect but can't measure, so can't prove it.

What we do know is that our CMO has told us that we haven't knocked it out of the park and that may be we can take a look at cancer. Sounds like a CR and more trials to me.

If you and your mates think this is such great buying why aren't you putting your cash where your mouth is.

I'll wait for the deal to be announced by the company or the administrators to be appointed.

Who knows BIOTRON might be a speculative uranium exploer soon.